Table 3.
Multivariate Analyses of Current ART Use and Virologic Suppression among Perinatally Infected Sample (n=649)
| Variable | Odds Ratio | 95% Confidence Interval |
p value |
|---|---|---|---|
| ART Use | |||
| Birth Sex (male vs. female) | .87 | .55–1.36 | .530 |
| Race (other vs. African-American) | .66 | .36–1.20 | .169 |
| Ethnicity (other vs. Latino) | 1.05 | 51–2.15 | .897 |
| Age (12–17 vs. 18+ years) | .66 | ..41–1.06 | .085 |
| Missed Appt. (≤1 vs. vs. 2+) | .48 | .30–.76 | .002 |
| ASSIST Current (≥4 on any substance) (no/yes) | .55 | .32–.95 | .033 |
| VL Suppression | |||
| Birth Sex (male vs. female) | 1.04 | .69–1.58 | .852 |
| Race (other vs. African-American) | .56 | .34–.95 | .030 |
| Ethnicity (other vs. Latino) | .64 | .35–1.16 | .141 |
| Age (12–17 vs. 18+ years) | .61 | .40–.92 | .018 |
| Sexual Orientation (heterosexual vs. gay/bisexual/other) | .52 | .26–1.05 | .068 |
| PI Regimen vs. All | .67 | .41–1.10 | .112 |
| NNRTI Regimen vs. All | 1.81 | .98–3.36 | .058 |
| ART ≥6 months (no/yes) | 2.48 | 1.09–5.63 | .030 |
| Missed Appt. (≤1 vs. vs. 2+) | .52 | .32–87 | .012 |
| ART Adherence ≥90% (no/yes) | 1.79 | 1.17–2.72 | .007 |
| CRAFFT (≥2 as clinically significant) (no/yes) | .60 | .38–.95 | .030 |
Note: ART = antiretroviral therapy; VL = viral load; PI = protease inhibitor; NNRTI = non-nucleoside reverse-transcriptase inhibitors; CRAFFT=Car, Relax, Alone, Forget, Friends, Trouble (keywords in a screening questionnaire to identify at-risk teen substance abusers; BSI = Brief Symptom Inventory).
For the purposes of these multivariate analyses, the authors used “Birth Sex” (male or female). Authors didn’t run transgender as a separate correlate simply because the numbers were very low and thus would have been difficult with such small numbers to find any meaningful differences.
= Clinically indicative: males ≤19, GSI≥1.71; females ≤ 19, GSI≥1.59; males ≥20, GSI ≥0.58; females ≥20, GSI ≥0.78).
p < .05 bolded.